These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2746860)

  • 41. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.
    Zhao WH; Hu ZQ; Okubo S; Hara Y; Shimamura T
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1737-42. PubMed ID: 11353619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. II. Effect of inoculum size.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Apr; 48(4):563-70. PubMed ID: 7783319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
    Snydman DR; McDermott LA; Jacobus NV
    J Chemother; 2005 Dec; 17(6):614-21. PubMed ID: 16433191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Caillon J; Grossi O; Le Mabecque V; Miegeville AF; Bugnon D; Batard E; Potel G
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2547-9. PubMed ID: 16801442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination of bacteriostatic and bactericidal drugs: lack of significant in vitro antagonism between penicillin, cephalothin, and rolitetracycline.
    Daschner FD
    Antimicrob Agents Chemother; 1976 Nov; 10(5):802-8. PubMed ID: 795370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fucoxanthin Potentiates the Bactericidal Activity of Cefotaxime Against Staphylococcus aureus.
    Nurcahyanti ADR; Lady J; Wink M
    Curr Microbiol; 2023 Jun; 80(8):260. PubMed ID: 37365295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic efficacy of cefodizime in combination with minocycline against systemic infection caused by methicillin-resistant Staphylococcus aureus in immunocompromised tumour bearing mice].
    Furukawa T; Shimizu C; Uji T; Miyake Y; Hyodo A; Deguchi K
    Jpn J Antibiot; 1993 Apr; 46(4):310-7. PubMed ID: 8515562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Measurement of MICs on 16 antimicrobial agents for freshly isolated methicillin-resistant Staphylococcus aureus strains].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1990 Apr; 43(4):623-35. PubMed ID: 2381034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].
    Shiritani Y; Yamaji S; Aoki A; Saigusa M; Yokoiyama S; Gato S; Tsuji A
    Jpn J Antibiot; 1988 Nov; 41(11):1591-9. PubMed ID: 3145343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
    Saionji K; Shitara S; Kobayashi I
    Jpn J Antibiot; 1990 Mar; 43(3):379-87. PubMed ID: 2374289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro].
    Młynarczyk A; Młynarczyk G; Luczak M
    Med Dosw Mikrobiol; 2005; 57(1):1-6. PubMed ID: 16130290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
    J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of antimicrobial peptides HNP-1 and hBD-1 on Staphylococcus aureus strains in vitro and in vivo.
    Bolatchiev A; Baturin V; Bazikov I; Maltsev A; Kunitsina E
    Fundam Clin Pharmacol; 2020 Feb; 34(1):102-108. PubMed ID: 31313350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population analysis of susceptibility to cefotaxime and desacetyl-cefotaxime in Staphylococcus and Enterobacteriaceae.
    Hansen BG; Søgaard P
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):243-7. PubMed ID: 3875967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. I. Synergistic action with minocycline].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
    Jpn J Antibiot; 1991 Dec; 44(12):1386-91. PubMed ID: 1798073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic Effect and Time-Kill Evaluation of Eugenol Combined with Cefotaxime Against Staphylococcus aureus.
    Lady J; Nurcahyanti ADR; Tjoa E
    Curr Microbiol; 2023 Jun; 80(8):244. PubMed ID: 37310571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.